Selected article for: "case fatality rate and meta analysis"
Author: Zhang, Hua; Han, Han; He, Tianhui; Labbe, Kristen E; Hernandez, Adrian V; Chen, Haiquan; Velcheti, Vamsidhar; Stebbing, Justin; Wong, Kwok-Kin
Title: Clinical Characteristics and Outcomes of COVID-19-Infected Cancer Patients: A Systematic Review and Meta-Analysis
  • Cord-id: vuxjkdmo
  • Document date: 2020_11_2
    • ID: vuxjkdmo
    Snippet: BACKGROUND: Previous studies have indicated Coronavirus disease 2019 (COVID-19) patients with cancer have a high fatality rate. METHODS: We conducted a systematic review of studies that reported fatalities in COVID-19 patients with cancer. A comprehensive meta-analysis that assessed the overall case fatality rate and associated risk factors was performed. Using individual patient data, univariate and multivariate logistic regression analyses were used to estimate odds ratios (OR) for each variab
    Document: BACKGROUND: Previous studies have indicated Coronavirus disease 2019 (COVID-19) patients with cancer have a high fatality rate. METHODS: We conducted a systematic review of studies that reported fatalities in COVID-19 patients with cancer. A comprehensive meta-analysis that assessed the overall case fatality rate and associated risk factors was performed. Using individual patient data, univariate and multivariate logistic regression analyses were used to estimate odds ratios (OR) for each variable with outcomes. RESULTS: We included 15 studies with 3019 patients, of which 1628 were men; 41.0% were from the UK and Europe, followed by the USA and Canada (35.7%) and Asia (China, 23.3%). The overall case fatality rate of COVID-19 patients with cancer measured 22.4% (95% confidence interval [CI] = 17.3% to 28.0%). Univariate analysis revealed age (odds ratio [OR] = 3.57; 95% CI = 1.80 to 7.06), male (OR = 2.10; 95% CI = 1.07 to 4.13), and comorbidity (OR = 2.00; 95% CI = 1.04 to 3.85) were associated with increased risk of severe events (defined as the individuals being admitted to the intensive care unit, or requiring invasive ventilation, or death). In multivariate analysis, only age greater than 65 years (OR = 3.16; 95% CI = 1.45 to 6.88) and being male (OR = 2.29; 95% CI = 1.07 to 4.87) were associated with increased risk of severe events. CONCLUSION: Our analysis demonstrated that COVID-19 patients with cancer have a higher fatality rate when compared with that of COVID-19 patients without cancer. Age and gender appear to be risk factors associated with a poorer prognosis.

    Search related documents:
    Co phrase search for related documents
    • active anticancer treatment and logistic regression analysis: 1, 2
    • active chemotherapy and acute myeloid leukemia: 1, 2
    • active chemotherapy and logistic model: 1
    • active chemotherapy and logistic regression: 1, 2
    • active chemotherapy and lung cancer: 1, 2, 3
    • active treatment and acute lymphoblastic leukemia: 1, 2, 3, 4
    • active treatment and acute myeloid leukemia: 1, 2, 3, 4, 5, 6, 7
    • active treatment and logistic model: 1, 2, 3, 4, 5, 6
    • active treatment and logistic regression: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
    • active treatment and logistic regression analysis: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14
    • active treatment and low quality: 1, 2, 3, 4
    • active treatment and lung cancer: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23
    • active treatment and lung cancer patient: 1
    • active tumor and lung cancer: 1
    • acute lymphoblastic leukemia and logistic regression: 1
    • acute lymphoblastic leukemia and logistic regression analysis: 1
    • acute lymphoblastic leukemia and low quality: 1
    • acute myeloid leukemia and logistic regression: 1
    • acute myeloid leukemia and lung cancer: 1, 2, 3, 4